SUBSCRIBERS
As biotech selling spreads, more weakness is seen for US health stocks
Published Sun, Oct 25, 2015 · 09:50 PM
New York
AFTER a four-year love affair with healthcare shares, investors are moving on.
Selling has spread from biotechs - shaken on Sept 21 when Hillary Clinton first tweeted concerns about drug prices - to other areas of the healthcare sector. Investors have been dumping shares of everything from hospitals to traditional pharmaceutical companies and insurers in recent weeks.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties
New weight-loss, diabetes drugs reach one in eight Americans
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife says private placement is to address urgent cash needs
Cordlife substantial shareholders lay out separate plans to address issues after AGM
Disney, Warner Bros Discovery launch US streaming bundle